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The pathogenesis of scleroderma is still elusive, although 
autoimmune mechanism involvement has been suggested. 
The present study was designed to investigate whether o r not 
rar scleroderma would appear as one of the symptoms in a 
recently described modc:l for autoimmune disease. The 
model is based on manipulation or reconsritution of the im-
mune system after lethal irradiation and syngeneic bone mar-
row transplantation by temporary administration of rhe im-
munosuppressive drug cyclosporinc-A. Withdrawal of 
cyclosporinc-A 6-12 wk after bone marrow transplantation 
Similar ity of lesions of scleroderma in humans and of pa-thology associa ted with chronic graft-versus-host diseaSe" aftcr allogeneic bone marrow transplantarion (BMT) in man and in rode-nts, has been documented [1.2]. Hence. chronic graft-versus-host (GVH) disease has been pro-
posed as a model for investigation of the" pathogenesis of sclero-
derma in man. 
The pathogcnesis of scleroderma is unkno~n, but autoimmunc 
phenomena ought play an important role 13J. However, from an 
immunologIC point of view. chronic GVH disease is not homolo-
gous to autoimmune disease. Therefore , we hav.c explore? the 
chronic phase of a recently dcscribed model of autolmmune dlSease 
in rats for concurrem development of scleroderma. 
1n this model an acure GVH-lih syndrome is elicited by a combi-
nation ofX-irradi.ation, autologous or syngeneic BMT. and tcmpo-
rary administration of cyclosporine-A (eyA) 14]. Because no genetic 
differences between bone marrow donors and recipients exist in this 
model. a classic GVH reaction cannot occur. H owever, man.ipula-
tion of the reconstitution of immunocompetent cells by eyA gives 
rise to auroinllntmC-reacrions in the recipient 15.6J. 
As chrome GVH disease is usually preceded by an episode of acute 
GVH disease. it was h)'pothesized that after recovery from the acute 
phasc o f CyA-induced auroimmuniry (eyA-At) . rats might develop 
pathology similar to chronic GVH disease. In this report the pat hol-
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Ahbreviations: 
BMT: bone: marrow lransplant 
CyA: cyclosporine: A 
CyA-AI: cyclosporine A-induced autoimmunity 
D.HSS: Dulbecco's balanced salt solution 
GVH: graft-versus-host 
SPF: specific parhogen-fre:e: 
gives risc to autoimmune reactions causing clinical pathology 
similar ro graft-versus-host disease. We discuss the ch ronic 
phase of this disease, approxim:Hely 30 wk afte r cyclospor-
ine-A was withheld at that time- abom one - third of the 
rats had developed histologic skin lesions comparable to 
those seen in patients with scleroderma. Therefore, we pro-
pose this model as a new, experimental autoimmune model 
for scleroderma in humans.] Imlest Dermato/ 93:6 10 - 615, 
1989 
ogy of the acme. in rermedlare. and chron ic phase of eyA-AI is 
descri be-d. 
MATERlALS AND METHODS 
Animals Fcmalc, specinc pathogen-free (SPF) Lewis (Lew; RTl1) 
rats were used as donors and rccipicms for synge nc-ic BMT. Female 
SPF DA (HTP) rats donated bone marrow to LEW recipient.s for 
allogeneic rransplantations. Rats wcre obtained from our own 
breeding stoc.k (Department of Anima,j Faciliti('.s, Universi ty of 
Limburg) or purchased from C harles River (Sulzfeld , West Ger-
many). Rats wcre used ar age 2 mo. 
Bone Marrow Transplantation BMT we.re performed accord-
ing ro dH,' described protocol [6). In brief. a bone marrow cell sus-
pension was prepared in Dulbecco's balanced salt so lution (DBSS) 
sllpplemcnred with 2% newborn cal f se rum. penicillin (100 V / ml) , 
:md strcptomydn (tOO J1g/ ml) . Rccipients were lethally X-irra-
di:ucd On day - ) wi th 9.6 Gy at 0 .7 Gy/ min using a Rontgen 
irradiator (Ph ilips MG 320. Hamburg, West Germany). On day O. 
reCIpient rats received 4 - 6 X 107 viable marrow cells in 1 ml DBSS 
intravenously into a rail vein . 
Administration of CyA eyA (donated by Sandoz Ltd .. Uden, 
Tht' Netherl ands/Basle. Switzerland) was dissolved in olive oi l at a 
conccnmuion of7.5 mg/ ml. The olive oil was heated to 60"C co 
improve dissol ution. Doses of7.5 mg CyA/ kg body weight were 
dail y administered subcuram:ous!y to recipients of syngeneic BMT 
and fO olle group of normal comral animals. CyA was given for a 
period of 40, 60. or 80 d. 
Clinical Scoring nf Pathology After withdrawal of CyA , rats 
were scored onc to fWO time-s a week for signs of disease: hyperemia 
of the skin . dcrmatitjs. and alopecia [7] . Scoring was performed by 
an observer not involved in thi s study. 
H istology Skin biopsy specimens were- taken from the breast, 
back. and/or paws o f animals with clinical signs ofCyA-AI. During 
life, sk in biopsy specimens were usually taken from the breast, as 
thi s area often exhibited c1 in icaJ pathology. Moreover, the ratS can-
not destroy rhe sutures at this site. Specimens were taken both in the 
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Table 1. Clinical Signs and Symptoms of Disease 
Disease 
During CyA 
Group N Administrarion 
Experiment:l.l 30 0/30 
(BMT+ eyA) 
Comrols' 16 0/16 
• Tnt' prescnct' of CyA-hl WaJi t'stOlnlished by nypat'mia, derrrtOltitis. ;md :alopecia. 
, Four of eight ~nHnal$ showed signs of eyA-AI. 
Weeks After Witbdn.wal of CyA 
2-4 >4 
Death eyA-AI" Deuh erA-AI 
8/ 30' 14/22 2/ 22 18/20 
0/16 0/16 0/ 16 0/16 
< This gtaup ill(;\uued oone-m:anow-gr:afteo, non-CyA-treated r.us: llonbone-murow-gDfu:d, eyA-treated rom: and llontrt':I!('d DU, 
CyA. cydosporinc- A; eyA-AI. cyclosporine i\ -induced autoimmunity; 8MT, bon(' ffl2no"'" rranspJ:anr. 
acute phase of disease (4-7 wk after withdrawal ofCyA). and in the 
later phase. 3-8 mo after withdrawal ofCyA. When an animal had 
died, or at the end of rhe expaimenr at auropsy, in addition ro 
biopsies from rhe skin, tissue samples were taken from several other 
organs including rhe tongue, digestive tracr, hean, lungs, kidney, 
liver, spleen, and salivary gland. 
Tissue samples we.re fixed in 0.1 M phospru. te-'buffered 4% for-
maldehyde for 24 - 48 h at 4" C, and embedded in paraffine. Tissue 
specimen were cut at 4IJ.m and stained with Hemaroxilin and Eo-
sine (H&E). Azan , and mluidine blue- according co standard proce-
dures. The Azan staining was applied to detect collagen and the 
roiuidine blue staining for idenrificarion of ma.u cdls. 
Control Groups Three diffe-renr conrrol groups were included in 
rhis srudy: 1) Age-matched-comrol rats (AM C) treated with the 
CyA solvent only (N = 4),2) AMC given CyA (N = 4), and 3) 
X-irradiared and syngeneic bone marrow rransplanted controls 
given rhe eyA solvem only (N = 8). 
RESULTS 
Development of Clinical Signs in CyA-Induced Autoim-
munity Results derived from MO cohorts of animals transplanted 
in separa[(' experimcnrs. In the fusr experimenr. eyA was given 
for 60 d (N = 5). In the second experiment CyA was given for 
40 (N = 19) or 80 (N = 5) d. As ,he duration of CyA administra-
tion did not influence the pattern of disease all data were pooled 
(Table I). 
No c1injcal signs of disease were obsen ted in animaJs duriug ad-
ministrarion of CyA. The firsr sign of disease dfrc[ widldrawal of 
eyA was frequently hyperemia of the skin. followed by the devel-
opment of alopecia around the nOse and on tbe chest. Thereafter. 
dermatitis was usually observed, and sometimes severe epider-
molysis. Apparently. as concluded from scratching by the animals, 
pnlrirus accompanied tbe dermatitis. In the final srage aJopecia was 
present allover rhe breast and on the lateral side of the paws (Fig 1). 
The back of the animals was less frequently affected, although some 
animals finally became completely nude. Approximately 65% of the 
animals treated with CyA developed rhis acute-phase pathology. 
usually 3 wk after wirhdrawal of the immunosuppressant (Table I). 
Afrer the acute phase of disease, the affected animals clinically 
recovered, although alopecia remained. The affected a.nimals ap-
peared to be viral, although their weigh t was reduced as compared 
with. contrOl animals. In th.e chronic phase. animals with CyA-AI 
were clinically indistinguishable from animals wi rh chronic graft-
versus~hos[ disease afrer allogeneic (DA - LEW) BMT (Fig 2). 
Usually. on the back of rhe affected animals the skin was tigh t, 
appeared "shiny," and thicker compared with conrrol animals. On 
the breast and paws there was an increase of skin folds. However. 
hardening of rhe skin. as prevailing in patients with scleroderma, 
could not be objectivdy assessed. 
O f the group of eight anirrulls nor affected by CyA-Al in the acute 
phase. cwo were killed inadvertedly du.ring erher anesthesia. Four 
m.ore animals developed clinical alopecia between 2-5 mo after 
wirhdrawal of CyA (Table I). 
None. of the rats of the three control groups showed any clinical 
sign of disease during the course of the expenmenr, except for 
radiation parhology (weightloss and sometimes diarrhea) in the 
llMT controls during rhe firsr week after X-irradiation. 
Histopathology Befo re eyA WithdrawaJ During rhe adrninis-
trarion ofCyA, 12 biopsy specimens were taken from a total group 
of eight bone mar:row-transplamed and eyA-treated animals. There 
was a marked decrease of subcutaneoiJs far in chese animals com-
pared with AMC. However, this reduction of subcutaneous far was 
also noriced in animals thar underwent BMT bur were nor rreated 
wirh eyA (4/ 4 rats). In two specimens takcn from different rars 
afrer 70 days of CyA administration. aslight inflammatory reaction 
situated around a single hair follicle was observed. 
Hjstopathology of the Acute Phase of CyA-AI T o study the 
hiswparhology of rhe skin in the acute phase of CyA-AI. biopsy 
specimens of the sk.in were take-n 4 (N = 5) and 7 (N = 8) weeks 
after withdrawal of CyA . .Biopsy specimens were taken from ani-
mals wi rh clinical manifestations of eyA-AI only. 
Varying degrees of GVH-like pathology was present in all biopsy 
specimens. This pathology encompassed sparse, diifuse infiltrates of 
Figure 1. Rat with :lIcut~ cydosporine-induced autoimmune di5e.lSe show. 
ing marked alopeci2 on bre:lls[ and extremities, 
612 nos IT At 
Figure 2. lbt with chronic cyclosporinr--induced a~toimmunr- disease 
(tlpptr) . syngeneic bone marrow transplanted control ron (midd/~) . 2nd rat 
with chronic graft-versus-hosr disease after allogeneic (DA - LEW) 
bom' marrow tr:msplamation (lowl!T). 
mononuclear cells in the dermis, especially around smal l hair folli-
cles in the upper derm.is, and at the dermal/ epidermal jUJlction. 
Local destruction of the epidermis with vacuolar degeneration of 
basal cells. and focal necrosis ofkerarinocytes. giving rise to Civatte 
bodies (eosinophil ic cells) were secn as well (Fig 3). ln these biopsies 
the epidermis was wider compared with that of control an imah, 
where it has one to twO cell layers only. Acanthosis and a hyper-
granular (coarse) stratum granulosum were usually observed . Fur-
thennore. myositis was frequently observed -an abnotmality ab-
sen t from control an imals. 
In all samples t.u..en at 7 wk post-C}'A withdrawal. foJljculiris 
was the most conspicuous abnormality. Folliculitis affected both 
small and la rge hair follicles in the dermis. and subdermal fat. 
Fibrosis of the subdermal region usually developed around hair 
follicles with an in flammatory react ion. This fibros is was rardy 
seen 4 w k after withdrawal of eyA (one in five rats), but readily 
observed at 7 w k after CyA withdrawal (seven of eight rats). 
In biopsies taken 7 wk after withdrawal of eyA, numerous mast 
cells could be observed. Mast cells were usually present in the lower 
dermis and in the subdermal fat, in those regions where increased 
fibrosis was also observed. 
In the conrrol groups no lesjons of GVH-like pathology were 
discernible. 
Histopathology of the Intermediate and Chronic Phase 
Biopsy specimens were taken 11 to 36 wk after withdrawal ofCyA. 
at intervals of 6-8 wk, co assess the histologic changes in the inter-
mediate and chronic phase of disease. 
In the intermediate phase (11 - 2 1 wk after CyA withdrawal), the 
severity of the described epidermal abnormali ties dimin.ished. Oc-
casionallya mi ld local mononuclear inflammation was still detect-
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Figure 3. Skill histology during acute cyclosporine-induced autoimmune 
disease. showing infiltr:uion of mononuclear cdls. destruction of th l:' epi-
dermis. and widening of the: epIdermis (H&E. X 400) 
able at the epidermal/ dermal junction. The epidermis decreased to 
its normal dlickness or remained only slightly thickened. Epidermal 
necrosis was no longer observed. T he dil1use inflammation of the 
dermis decreased as wel1. bUl inflammation of the hair follicles 
persisf-f"d (Fig 4). It is noteworthy chac inflammation of the larger 
hair follicles, usually si tuated in the lower dermis or su~derma l fat. 
Was mOst prominent. whereas around the smaller follicles in the 
dermis usually no inflammarory reaction was detected. In the upper 
dcnnis. rhe number of hair follicles was reduced. and in those 
present. degeneration including the absence of the hair(s) was seen. 
In the dermis. hyperplasia of sebaceous glands was &equcndy 
observed. Furthermore, hypcrvascularis3rion \Vas noticed, asso-
ciated with markedly enlarged venules, mainly localized in the sub-
dermal far. An increased number of mast ceJls was still observed at 
the same localization described for the acute phase. Also in this 
phase of disease thcy were si tuated in those areas where increased 
fib rosis was presen t. 
As described. an increase of fibrosis. usually starting around the 
larger hair follicles. could be observed from as early as 7 wk afte,r 
withdrawal of CyA. Fibrosis still progressed in the later phase of 
disease . As a consequence, the (remain ing) subcuraneous far often 




Figure ... Skin histology durin g intermediate phase of cyclosporine-in-
duced autoimmune disease. Note continuous inflammation of hair follicles 
and increase of coll:lgen deposition in [he subdermal fat region (H&E, 
X 400) (For control skin $ee Fig 58) 
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Table II. Presence of GVH-like H istopathological Skin Lesions-
During 
Cy-A 
Group Administration 4 -7 wk 
Experimcntal 2/ 1 2~ \3/ \3 
(BMT + Cy A) 
ControlsJ 0/12 0/12 




Time After Withdr.awal of Cy-A 









~ A slight Infl~mm~tOry reilcriofl. sHlllted around ~ h:ur foillelt' 1-" :1$ observed in two b,opsy specimens ukcn ~fter 70 d of CyA .1clminiStruion . 
• All ;ani m~ls with sclcrodcrm;alike lesions also showed inR~mllUfOry changes dunng th t' mrumedi;a[e ph.ll$c of dlsc;aSC". 
J Thi~ group includt'd bont'-marrow-graftcd. lIon-CyA-trcated rats: llonoollC'"-nurrow.graflt'd. C}'A-m~ated rats; and nontreated r:lU. 
Ahbrc\'i;l,tlons u in ! "ble L 
subdermal fat region appeared very thin. but later their thickness 
increased. In the mOst conspicuous cases, subcutaneous fat was com-
plctely absent. and was replaccd by collagen. 
In the chronic phase of disease (6-8 mo post-er A withdrawal), 
th ree different parcerru of dermal lesions could be distinguished 
(Table If). In tbe group exhibiting the fi rst pan ern rccovery from 
the inflammatory reaction observed earlier had occurred, and no 
signs of ch ronic disease were discernible (N = 2). In biopsy speci-
mens taken from these rats , a reduced number of normal hair folli-
cles \vas the only abnormality, In the second group. biopsies showed 
a spectrum of changes similar to chat of the intermediate phase of 
disease: pers istence of the inflammarory reacrion. manifestation as a 
fo lliculitis in tbe subdermal fat. and an increase of collagen in the 
subcutaneous region (N = 6). Finally, in the third group. in.flam-
matory reactions were no longe r seen or had diminished. However. 
in these biopsies an increase ofhomogcneous collagen and complete 
absence of subcutaneous far was noticed (N = 3) (Fig 5). Addition-
ally rhert' was also a decrease of normal , vital hair follicles in these 
biopsy specimens. They showcd striking si milarities to the histopa-
thology observed in the late phase of scleroderma in humans. 
T he histologic scudy of o ther organs revealed no pathology, ex-
cept for rhe tongue. In this organ. severe inflammatory reactions 
were encountered in the acute phase of disease. In rhe later phases 
rhe inflammatory reaction pers.isred. and fibrosis became apparent. 
DISCUSS ION 
In this re-poft the clinical signs and symptoms and the histologic skin 
lesions of (.he early. intermediate, and late- phases of cyclosporine-
induced autoimmune disease in the rat were described. Patbology of 
the acute phase of the disease has been reported previously, but 
description of the intermediatc and chronic phase has, to our knowl-
edge, not bee-n published. In this (nodel, disease is elicited by a 
com bi nation of lethal X-irradiation, syngeneic bone marrow trans-
plants and the administration of cyclosporine-A fo r 40 - 80 d. A 
disba l:lIlce of regulatory cells normally preventing immune reac-
tions to " self" antigens is likely to be the cause of acute disease in 
th is model 151. 
After wi thdrawal ofCyA, animals developed a clinical syndrome 
ind istinguishable from -acu te GVH disease after allogeneic bone 
marrow transplantation. This syndrome bas been described by 
others [4J. The histopa thological lesions of the skin duri.ng the acute 
phase of di sease described in this study were similar to those re-
pOrlt:d hy others [71 and resembled those described dming an aCute 
graft-versus-host reaction after allogeneic bone marrow trans-
plantation f8]. Histopa thological abnormalities included a lichen 
pbnuslike inflammatory rcaction in the epidermis and around 
smaJl, dermal hair follicles. 
After the acute phase of disease, which was lethal in a few ani-
mals, the animals recovered c1 inically. This contrasts other exper}-
mcnts w here most animals died during the acute phase of d isease [4}. 
In only one stud y applying this model was the survival of a substan-
tial percentage of animals mentioned 19]. As in our studies specific 
pathogen-frec an imals we re. used. Therefore, the absence of con-
ccmitant ~nfeC[.ious diseases might explain the high survival rate in 
our expenments. 
In [he chronic phase of disease, animals showed clinical pathol-
ogy comparable to that seen in animals with classic chronic gtaft-
versus-host disease . The pattern of skin abnormalities in chronic 
GVH disease has been suggested to be similar to scleroderma in 
humans 11,1 0,111. H owever. apart from tbe observation of a thicker 
A 
B 
Figure. S. A , Skil\ bi<)psy t,.kt:n dUf\ng chronic: C)'c1o~porine-incluccd au-
toimmune diseJS('. Marb::d increase of collagen deposition can be obse-rved 
and as a consequence complete absence of subcutaneous far , No inflamma-
tory reaction is dctectable an)'more (H&E, X 60). B. Skin biopsy of animal 
5 mo after syngclleic HMT witho ut cyclosporine-A adOlinistr.nion 
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and dghter skin on the back of some anirru.ls. we could not objec-
tively asSess hardening of the skin of these rats comparable to chac 
ex.isting in parients with scleroderma. 
The hisropathological lesions developing after (he acme phase 
were similar to those' described in chronic GVH disease: a (slight) 
inflammatory reaceion. decrease:' of adnexa. increased fibrosis. ,md 
the disappearance of subcutaneous fat. The laner phenomenon is 
known ro be One of the most specific abnormalities in parients wirh 
scleroderma 112]. One of the most prominent abnonnalities noticed 
in our study was a rtl3.rked Folliculins. This foHiculitis h3.s nor been 
described in mosr of the studies on the pathology of GVH disease. 
although Folliculiris has been memioned as an aspect of this disease 
113, and Beschorner. personal communication]. 
Increase of collagen fibers was noticed as cady as 7 wk after wirh-
drawal of cyclosporine-A. and biopsy specimens taken at this time 
showed signs of acute- as we-II as of ch ronic disease. We: did not 
ohserve an increase of collagen fibers in the subcutaneous region in 
biopsy specimens taken 4 wk after withdrawal of cyclosporine-A, as 
documented earli er in a comparable study (14]. 
Based on histologic similarities, chronic GVH disease has been 
suggested as a model for scleroderma by many authors [1.10.15]. 
H owever. substantial diH'erences have be.en noticed as well 116J. 
One of the main distinctions is the localization of increased sclero-
sis. In chronic GVH disease. increased sclerosis is often situated in 
the upper dennis, whereas in scleroderma in man. abnormal colla-
gen deposition is usuall), restrictcd to the lower dermis and the 
subcutaneous region [16J. In the- model described in this study. thc 
increase of collagen was usually observed in the lower dennis and 
subcutaneous region. starring around the hair follicles. The subcuta-
neous fat was gradually replaced by collagen. Therefore. with re-
spect to the localization of abnormal fibrosis, this model shows 
stronger similari ty with scleroderma in man than does chronic 
GVH disease after allogeneic bone marrow transplantation. 
It should be noted that in mOSl of the animals there was st ill a 
marked inflammatory reaction 6 - 8 mo after withdrawal of cyclo-
sporin-A. Whether this reaction will further decrease to evolve into 
a more chronic phase of disease in more animals remains to be seen. 
In comparing cyclosporine-induced experimental autoimmune dis-
ease and scleroderma it is important to realize that eady scleroderma 
already involves a period of three years of disease [17J. However, 
dut" to the life span of a rat, the. follow-up period in chis model is far 
less than the- durarion of disease in patients with scleroderma. This 
difference may account for the low incidence ofJesions akin to those 
of lace scleroderma. 
Mast cells were abundanrly present from 7 wk after withdrawal 
of eyA in most of the biopsy specimens. These cells were usually 
seen around inflamed hair follicles at rhe sire of deposition of colla-
gcn. Both in paticnts with scleroderma and in chronic GVH disease, 
mast cells have been related co abnormal sclerosis 117 -19J. The roJe 
of mast cells in this model still need.~ clarification, bur their presence 
in association with the observed deposirion of colbgcn suggests a 
causal relationship in this model as wei\. 
Aparr from rhe skin, no orher organs known ro be often involved 
in diffuse- systemic sclerosis showed any abnormalities in this model. 
Thus, che model appears to represent tbe.limited cutaneous sclero-
derma subrype of scleroderma 1201· 
The presC'nce of capillary abnormalities in the skin of rats with 
chronic GVH disease, analogous to those observed in patiencs with 
scleroderma, supports experimental chronic GVH disease as a 
model for sclerodenna in humans 121]. Attempts to demonstrate in 
vivo microvascular abnonnalities in the present model were not yet 
successfuJ (data not shown). Possibly, with prolonged follow-up, 
these abnormalit ies might still develop. Furthermore. larger groups 
of anima.ls with sclerodermalike pathology have to be studied to 
establish concl usively the 2bsence or presence of microv2scular pa-
thology in this model. 
In conclusion. the induction of autoimmune disease by combina-
tion of lethal X-irradiation, syngeneic bone marrow transplanta-
tion. and temporary administration of cyclosporine-A yields histo-
pathological lesions similar to those encountered in chronic GVH 
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disease. The local ization of collagen deposition in this model shows 
even stronger similarity to rhat seen in human scleroderma than the 
localization of collagen deposition in chronic GVH disease. Because 
of the pathophysiologic mechanism of this model. it can be secn 3S a 
first autoimmune model for the pathogenesis of the histologic le-
sions of (I.imited, curaneous) scleroderma ill humans. 
It is unlikely that the primary events of scleroderma are in any 
respecr rcl.ued to rhe described model, because acure graft-versus-
host· like pathology or epidermal lesions have nOt been reported in 
scleroderma. How could rhis model the-n br related to scleroderma? 
The parallel between the experimental model and scleroderma in 
humans could be- th2f me- acute phase of cycJosporine-induced au-
toimmune disease induces the expression of neo- Or autoanrigens, 
that support a prolonged (auto-)immunc reaction. This continuous 
{auto-)immune reaction might be comparable to the pathophysio-
logic process of scleroderma in humans. The identiftcation of the 
neo- or autoantigens in the experimental model might trace the 
antigens responsible for tbe autoimmune reaction leading to sclero-
derma in humans. 
The ~xpm tulmicol assiSIIHlU 4 Marit-Josr W.N. IIQII Jt Gaar is gratifully DC· 
k,, ()u,ftJ~~.J.. 
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